Inpremzia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inpremzia, covering 2023-04-20 to 2023-04-20. Get the full timeline:
Most recent: EMA Withdrawn: Inpremzia (insulin human (rDNA)) — Baxter Holding B.V.